AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients (Q45367463)
Jump to navigation
Jump to search
scientific article published on 31 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients |
scientific article published on 31 July 2013 |
Statements
1 reference
AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients (English)
1 reference
1 reference
Kevin J Martin
1 reference
Karen Pickthorn
1 reference
Saling Huang
1 reference
Geoffrey A Block
1 reference
Andrew Vick
1 reference
David A Power
1 reference
Gregory Bell
1 reference
31 July 2013
1 reference
1 reference
Identifiers
1 reference